Skip to main content
SpringerLink
Log in

Abemaciclib/methylprednisolone

Interstitial lung disease: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Chen Y, et al. Characteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in Japan. Breast Cancer 28: 710-719, No. 3, May 2021. Available from: URL: http://doi.org/10.1007/s12282-020-01207-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abemaciclib/methylprednisolone. Reactions Weekly 1860, 17 (2021). https://doi.org/10.1007/s40278-021-97472-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-97472-2

Search

Navigation